MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Vaxcyte, Inc. Common Stock

PCVX

#848
Vaxcyte, Inc. Common Stock
61.7400
+3.31%
Sector:
Base:
Profit Currency:
Daily Range
61.7400
61.7400
Year Range
39.8700
64.7850
Daily Change
+3.31%
Monthly Change
+13.62%
6 month change
+45.96%
Year Change
+45.96%
Previous Close
59.7600
Open
61.7400
Bid
Ask
Low
61.7400
High
61.7400
Volume
145
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. PCVX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

News

Investing Investing
PCVX
2026.02.25
BTIG raises Vaxcyte price target to $89 on vaccine breadth edge
Investing Investing
PCVX
2026.02.25
Leerink raises Vaxcyte stock price target on vaccine pipeline expansion
Seeking Alpha Seeking Alpha
PCVX
2026.02.25
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Zacks Zacks
JAZZ ACAD OVV PCVX
2026.02.18
Ovintiv to Report Q4 Earnings: What's in Store for the Stock?
Investing Investing
PCVX
2026.02.02
Vaxcyte closes $632.5 million public offering of common stock
Investing Investing
PCVX
2026.01.30
Vaxcyte prices $550 million public offering of common stock
Seeking Alpha Seeking Alpha
RVMD ABBV FIX FTAI ABVX
2026.01.30
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Investing Investing
PCVX
2026.01.29
Vaxcyte launches $500 million public offering of common stock
Seeking Alpha Seeking Alpha
LABD XBI LABU MRNA RVMD
2026.01.26
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD)
Investing Investing
PCVX
2026.01.23
Cantor Fitzgerald reiterates Overweight rating on Vaxcyte stock
Benzinga Benzinga
PCVX
2026.01.23
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Vaxcyte (NASDAQ:PCVX)
Investing Investing
PCVX
2026.01.06
Evercore ISI reiterates Outperform rating on Vaxcyte stock amid CDC changes

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd